IO Biotech, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| NOVO HOLDINGS A/S | 11/14/2025 | 2.51 M | $912.27 K | -25.10% | 3.81% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 1.53 M | $554.05 K | 100.00% | 2.32% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 1.39 M | $505.58 K | 100.00% | 2.11% |
| MARSHALL WACE, LLP | 11/13/2025 | 1.05 M | $378.95 K | -50.00% | 1.60% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 799.95 K | $290.38 K | -50.47% | 1.21% |
| MORGAN STANLEY | 11/14/2025 | 668.40 K | $242.70 K | 2.25% | 1.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 591.18 K | $214.66 K | 100.00% | 0.90% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 547.32 K | $198.73 K | 292.90% | 0.83% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 250.00 K | $90.78 K | 100.00% | 0.38% |
| XTX TOPCO LTD | 11/14/2025 | 179.21 K | $65.07 K | 513.95% | 0.27% |
| QUADRATURE CAPITAL LTD | 11/13/2025 | 83.38 K | $30.28 K | 100.00% | 0.13% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2025 | 75.00 K | $27.23 K | 0.00% | 0.11% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 66.56 K | $24.17 K | 100.00% | 0.10% |
| VIRTU FINANCIAL LLC | 11/14/2025 | 39.06 K | $14.00 K | 100.00% | 0.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 33.31 K | $12.09 K | 0.00% | 0.05% |
| NEWEDGE ADVISORS, LLC | 11/17/2025 | 25.69 K | $9.33 K | 6.09% | 0.04% |
| HILTON CAPITAL MANAGEMENT, LLC | 11/12/2025 | 25.51 K | $9.26 K | 100.00% | 0.04% |
| PKS ADVISORY SERVICES, LLC | 11/12/2025 | 19.50 K | $7.08 K | 100.00% | 0.03% |
| UBS GROUP AG | 11/13/2025 | 7.01 K | $2.55 K | -47.11% | 0.01% |
| CITIGROUP INC | 11/10/2025 | 1.29 K | $469 | 311.47% | 0.00% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 122 | $44 | -7.58% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| SECTORAL ASSET MANAGEMENT INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| PFM HEALTH SCIENCES, LP | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VIVO CAPITAL, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 11/13/2025 | 0 | $0 | -100.00% | 0.00% |
| MAREX GROUP PLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| DAUNTLESS INVESTMENT GROUP, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
IO Biotech, Inc. institutional Ownership - FAQ's
During the previous two years, 34 institutional investors and hedge funds held shares of IO Biotech, Inc.. The most heavily invested institutionals were:
Novo Holdings A/S: 2.51 M
Ikarian Capital, LLC: 1.53 M
MILLENNIUM MANAGEMENT LLC: 1.39 M
MARSHALL WACE, LLP: 1.05 M
BANK OF AMERICA CORP /DE/: 799,953
MORGAN STANLEY: 668,402
15.02% of IO Biotech, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 9.90 M shares in the last 24 months. This purchase volume represents approximately $4.77 M in transactions.